Abstract
The identification of small drug-like compounds that selectively inhibit the function of biological targets has historically been a major focus in the pharmaceutical industry, and in recent years, has generated much interest in academia as well. Drug-like compounds are valuable as chemical genetics tools to probe biological pathways in a reversible, dose- and time-dependent manner for drug target identification. In addition, small molecule compounds can be used to characterize the shape and charge preferences of macromolecular binding sites, for both structure-based and ligand-based drug design. High-throughput screening is the most common experimental method used to identify lead compounds. Because of the cost, time, and resources required for performing high-throughput screening for compound libraries, the use of alternative strategies is necessary for facilitating lead discovery. Virtual screening has been successful in prioritizing large chemical libraries to identify experimentally active compounds, serving as a practical and effective alternative to high-throughput screening. Methodologies used in virtual screening such as molecular docking and scoring have advanced to the point where they can rapidly and accurately identify lead compounds in addition to predicting native binding conformations. This chapter provides instructions on how to perform a virtual screen using freely available tools for structure-based lead discovery.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Walters, W. P., Stahl, M. T., and Murcko, M. A. (1998) Virtual screening – an overview. Drug Discov Today 3: 160–178.
Shoichet, B. K. (2004) Virtual screening of chemical libraries. Nature 432: 862–865.
Kitchen, D. B., Decornez, H., Furr, J. R., and Bajorath, J. (2004) Docking and scoring in virtual screening for drug discovery: Methods and applications. Nat Rev Drug Discov 3: 935–949.
Schneider, G., and Bohm, H. J. (2002) Virtual screening and fast automated docking methods. Drug Discov Today 7: 64–70.
Morris, G. M., Goodsell, D. S., Halliday, R. S., Huey, R., Hart, W. E., Belew, R. K., and Olson, A. J. (1998) Automated docking using a Lamarckian genetic algorithm and an empirical binding free energy function. J Comput Chem 19: 1639–1662.
Huey, R., Morris, G. M., Olson, A. J., and Goodsell, D. S. (2007) A semiempirical free energy force field with charge-based desolvation. J Comput Chem 28: 1145–1152.
Wang, R. X., Lai, L. H., and Wang, S. M. (2002) Further development and validation of empirical scoring functions for structure-based binding affinity prediction. J Comput-Aided Mol Des 16: 11–26.
Chen, Z. G., Li, Y., Chen, E., Hall, D. L., Darke, P. L., Culberson, C., Shafer, J. A., and Kuo, L. C. (1994) Crystal-Structure at 1.9-Angstrom Resolution of Human-Immunodeficiency-Virus (Hiv)-Ii Protease Complexed with L-735,524, an Orally Bioavailable Inhibitor of the Hiv Proteases. J Biol Chem. 269: 26344–26348.
Milne, G. W. A., and Miller, J. A. (1986) The Nci Drug Information-System.1. System Overview. J Chem Inf Comput Sci 26: 154–159.
Wang, R. X., Lu, Y. P., and Wang, S. M. (2003) Comparative evaluation of 11 scoring functions for molecular docking. J Med Chem 46: 2287–2303.
Charifson, P. S., Corkery, J. J., Murcko, M. A., and Walters, W. P. (1999) Consensus scoring: A method for obtaining improved hit rates from docking databases of three-dimensional structures into proteins. J Med Chem 42: 5100–5109.
Wang, R. X., and Wang, S. M. (2001) How does consensus scoring work for virtual library screening? An idealized computer experiment. J Chem Inf Comput Sci 41: 1422–1426.
Clark, R. D., Strizhev, A., Leonard, J. M., Blake, J. F., and Matthew, J. B. (2002) Consensus scoring for ligand/protein interactions. J Mol Graph Model 20: 281–295.
Berman, H. M., Westbrook, J., Feng, Z., Gilliland, G., Bhat, T. N., Weissig, H., Shindyalov, I. N., and Bourne, P. E. (2000) The Protein Data Bank. Nucl Acid Res 28: 235–242.
Ihlenfeldt, W. D., Voigt, J. H., Bienfait, B., Oellien, F., and Nicklaus, M. C. (2002) Enhanced CACTVS browser of the open NCI database. J Chem Inf Comput Sci 42: 46–57.
Morris, G. M., Huey, R., and Olson, A. J. (2008) Using AutoDock for ligand-receptor docking. Curr Protoc Bioinformatics Chapter 8: Unit 8.14.
Irwin, J. J., and Shoichet, B. K. (2005) ZINC – A free database of commercially available compounds for virtual screening. J Chem Inf Model 45: 177–182.
Acknowledgments
This work was supported in part by NIH grant GM 68460 (G.R.M.), the Washington University Cancer Biology Pathway (Y.T.T.), and the NIH Vision Sciences Training Grant (Y.T.T.).
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2011 Springer Science+Business Media, LLC
About this protocol
Cite this protocol
Tang, Y.T., Marshall, G.R. (2011). Virtual Screening for Lead Discovery. In: Satyanarayanajois, S. (eds) Drug Design and Discovery. Methods in Molecular Biology, vol 716. Humana Press. https://doi.org/10.1007/978-1-61779-012-6_1
Download citation
DOI: https://doi.org/10.1007/978-1-61779-012-6_1
Published:
Publisher Name: Humana Press
Print ISBN: 978-1-61779-011-9
Online ISBN: 978-1-61779-012-6
eBook Packages: Springer Protocols